Veracyte to Present at Upcoming Investor Conferences

Rhea-AI Summary

Veracyte (Nasdaq: VCYT) announced its participation in two virtual investor conferences. Bonnie H. Anderson, chairman and CEO, along with Marc Stapley, incoming CEO, will speak at the William Blair Growth Stock Conference on June 1, 2021, at 11:20 a.m. Central Time and at the Jefferies Virtual Healthcare Conference on June 4, 2021, at 11:30 a.m. Eastern Time. Live audio webcasts will be available on Veracyte's website, with replays accessible for 90 days post-event.

Veracyte specializes in genomic diagnostics, offering tests for various cancers and diseases to improve patient care.

Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, announced today that Bonnie H. Anderson, chairman, chief executive officer and incoming executive chairman, and Marc Stapley, incoming chief executive officer, are scheduled to participate in two upcoming virtual investor conferences:

• William Blair Growth Stock Conference
  Fireside Chat on Tuesday, June 1, 2021, at 11:20 a.m. Central Time

• Jefferies Virtual Healthcare Conference
  Presentation on Friday, June 4, 2021, at 11:30 a.m. Eastern Time

Live audio webcasts of the company’s presentations will be available by visiting Veracyte’s website at http://investor.veracyte.com/events-presentations. Replays of the webcasts will be available for 90 days following the conclusion of each live presentation broadcast.

About Veracyte

Veracyte (Nasdaq: VCYT) is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company’s growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company’s tests in lung cancer, prostate cancer, breast cancer, thyroid cancer, bladder cancer and idiopathic pulmonary fibrosis are available to patients and its lymphoma subtyping and renal cancer tests are in development. With Veracyte’s exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide. Veracyte is based in South San Francisco, California. For more information, please visit www.veracyte.com and follow the company on Twitter (@veracyte).

View source version on businesswire.com: https://www.businesswire.com/news/home/20210526006025/en/

FAQ

What events is Veracyte (VCYT) participating in June 2021?

Veracyte is participating in the William Blair Growth Stock Conference on June 1, 2021, and the Jefferies Virtual Healthcare Conference on June 4, 2021.

When will Veracyte's presentations take place?

The William Blair conference fireside chat is on June 1, 2021, at 11:20 a.m. Central Time, and the Jefferies conference presentation is on June 4, 2021, at 11:30 a.m. Eastern Time.

Where can I watch Veracyte's investor presentations?

Live audio webcasts can be accessed on Veracyte's website, with replays available for 90 days after the presentations.

What does Veracyte specialize in?

Veracyte specializes in genomic diagnostics, providing tests that improve patient care by informing diagnosis and treatment in cancer and other diseases.